Literature DB >> 4851484

Editorial: A plea for the "naturalistic" study of medicines.

L Lasagna.   

Abstract

Keywords:  Professional Patient Relationship

Mesh:

Year:  1974        PMID: 4851484     DOI: 10.1007/bf00560373

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  7 in total

1.  Clinical trials. Simple megatrials are not sufficient.

Authors:  D Barer
Journal:  BMJ       Date:  1999-04-24

Review 2.  Drug utilisation studies as tools in health economics.

Authors:  J A Sacristán; J Soto
Journal:  Pharmacoeconomics       Date:  1994-04       Impact factor: 4.981

3.  Placebos and controlled trials under attack.

Authors:  L Lasagna
Journal:  Eur J Clin Pharmacol       Date:  1979-07       Impact factor: 2.953

4.  Clobazam: single or divided doses?

Authors:  C Arnau; J M Costa Molinari; C Piña; C Vallvé
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

5.  A naturalistic cohort study on effectiveness, safety and usage pattern of an over-the-counter nicotine patch. Cohort study on smoking cessation.

Authors:  Joerg Hasford; Karl Olov Fagerstrom; Knut-Olav Haustein
Journal:  Eur J Clin Pharmacol       Date:  2003-07-25       Impact factor: 2.953

6.  A naturalistic study of hypertension in a rural U.K. community. 2 Years results.

Authors:  P J Fell; J M Shakespeare; N P Watson; H F O'Donnell
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

7.  Current methods and challenges for acute pain clinical trials.

Authors:  Ian Gilron; Daniel B Carr; Paul J Desjardins; Henrik Kehlet
Journal:  Pain Rep       Date:  2018-04-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.